KANEMITE® Miticide Approved for Use in Canada
Registration for use on apples, pears and field-grown ornamentals.
CARY, N.C. (December 19, 2007) –Arysta LifeScience North America today announced the Pest Management Regulatory Agency (PMRA) approval of Kanemite® 15 SC Miticide. With the approval of Kanemite, Canadian apple, pear and field ornamental growers gain access to one of the most effective miticides on the market today.
“With its rapid knockdown and long-lasting residual activity on European red and two-spotted spider mites, Kanemite offers apple and pear growers excellent control of these troublesome pest mites with a single rate of application,” says Mark McLear, Business Manager, Horticulture for Arysta LifeScience in Canada. Plus, Kanemite offers field ornamental growers control of both two-spotted and spruce spider mites.
Kanemite also fits well in most IPM programs because of the low impact on predacious mites, honeybees and other beneficial species. Plus, the unique mode of action of the active ingredient – acequinocyl – has no known cross-resistance, making Kanemite an ideal choice to help manage mite resistance.
“Kanemite will be an excellent tool used as part of any Integrated Pest Management program in orchards and field-grown ornamentals” McLear says.
Kanemite offers growers additional value-added benefits including activity on all mite life stages, a Reduced Risk EPA classification and a Restricted Entry Interval of only 12 hours. Apple and pear growers also benefit from a relatively short Pre-harvest Interval of just 14 days.
Headquartered in Tokyo, Japan, Arysta LifeScience is the world’s largest privately held crop protection and life science company with 2006 revenues of JPY124.1 billion (US$1 billion). An entrepreneurial provider of crop protection and life science products in more than 125 countries worldwide, Arysta LifeScience specializes in marketing and distribution of respected crop protection brands and life science products in harmony with the needs of global partners. More information on the company is available at: www.arystalifescience.com.
For further information, contact:
Arysta LifeScience North America